HMGB1 and head and neck squamous cell carcinoma: Therefore, in our opinion, compared to patients with HMGB1 cytoplasmic expression, HNSCC patients with both HMGN1 cytoplasmic expression and high expression of PD-L1 would be expected to get more benefit from anti-PD-L1/PD-1 therapy.